William H. Theodore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William H. Theodore has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
William D. Gaillard
Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland
9 shared publicationsSusumu Sato
Clinical Epilepsy Section, National Institutes of Neurological Disorders and Stroke National Institutes of Health Bethesda MD
8 shared publications- Gretchen Lano Birbeck
Epilepsy Division, Department of Neurology University of Rochester Rochester New York USA
6 shared publications Sara K. Inati
National Institutes of Health
6 shared publications- Daniel M. Goldenholz
Harvard Medical School Boston Massachusetts USA
5 shared publications Peter Herscovitch
From the Clinical Epilepsy Section, National Institutes of Neurological Disorders and Stroke (A.M., A.F., I.D., W.H.T.), PET Department, Clinical Center (P.H.), and Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health (A.N.), NIH, Bethesda, MD; and Clinical Neuroimaging Laboratory (D.M.C.), Departments of Anatomy & Psychiatry, National University of Ireland Galway, Galway, Ireland
5 shared publications
Latest Publications
- 15 May 2026
- Published by Elsevier in Epilepsy Research
- Vol. 225, 107826
Is temporal lobe epilepsy a progressive disease? Insights from a 5-HT1A receptor partial volume correction study
- 15 May 2026
- Published by Elsevier in Epilepsy Research
- Vol. 225, 107826
Is temporal lobe epilepsy a progressive disease? Insights from a 5-HT1A receptor partial volume correction study
- Open Access
- 10 March 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 137, 112-120
New onset seizure etiologies and outcomes among adults with HIV in the era of broadly available antiretroviral therapies
- 10 March 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 137, 112-120
Open AccessNew onset seizure etiologies and outcomes among adults with HIV in the era of broadly available antiretroviral therapies
- Open Access
- 19 December 2025
- Published by Wiley in Epilepsia Open
- Vol. 11 (1) , 230-239
Distinct medial temporal volumetric signatures in extra‐medial temporal lobe lesional epilepsy
Objective: To quantify amygdala and hippocampal volumetric asymmetries in patients with drug‐resistant epilepsy (DRE) and extra‐medial temporal lesions (EMTLs) and to assess the prevalence of structural alterations relative to drug‐resistant temporal lobe epilepsy (TLE), extratemporal lobe epilepsy (ETLE), and healthy individuals. Methods: Retrospective cross‐sectional study of 298 participants evaluated at the NIH Clinical Center (2004–2023), including 252 patients with focal DRE and 46 healthy volunteers. Of the DRE cohort, 63 had lateralized EMTL (48 left, 15 right). High‐resolution brain MRIs were segmented and analyzed to obtain normalized amygdala and hippocampal volumes. An asymmetry index (AI) assessed directionality, and absolute AI measured magnitude. Atrophy and hypertrophy were defined relative to healthy medians using robust dispersion thresholds. Group comparisons incorporated correction for multiple testing. Results: Dual pathology with mesial temporal sclerosis was radiologically identified in 20.6% of EMTL cases, predominantly ipsilateral. Adjusted amygdala and hippocampal volumes did not differ significantly across groups, and consistent amygdala atrophy was not observed. Left EMTL showed increased hippocampal asymmetry magnitude and a 39.6% prevalence of ipsilateral hippocampal atrophy, comparable to left TLE (34%). Right EMTL showed loss of the physiologic left‐smaller‐than‐right hippocampal pattern, with hypertrophy in the right amygdala (40%), left amygdala (46.7%), and contralateral hippocampus (40%), as well as ipsilateral hippocampal atrophy in 26.7%. Significance: We found mesial temporal volumetric changes in a significant proportion of EMTL patients. Directional, magnitude, and outlier‐based analyses help disentangle coexisting atrophy and hypertrophy, revealing potential compensatory network‐level changes in EMTL‐associated DRE not previously identified. Plain Language Summary: This study looked at changes in two brain structures, the amygdala and hippocampus, in people with treatment‐resistant epilepsy associated with lesions outside the medial temporal lobe. We found that patients with lesions on the left side often had a small left hippocampus, while those with right‐sided lesions showed more complex patterns, including enlargement of both the amygdala and left hippocampus and less frequent small right hippocampus. These findings suggest that detailed measurements of brain asymmetry can uncover changes missed by standard assessment and may help doctors better locate seizure activity and plan treatments.
- 19 December 2025
- Published by Wiley in Epilepsia Open
- Vol. 11 (1) , 230-239
Open AccessDistinct medial temporal volumetric signatures in extra‐medial temporal lobe lesional epilepsy
Objective: To quantify amygdala and hippocampal volumetric asymmetries in patients with drug‐resistant epilepsy (DRE) and extra‐medial temporal lesions (EMTLs) and to assess the prevalence of structural alterations relative to drug‐resistant temporal lobe epilepsy (TLE), extratemporal lobe epilepsy (ETLE), and healthy individuals. Methods: Retrospective cross‐sectional study of 298 participants evaluated at the NIH Clinical Center (2004–2023), including 252 patients with focal DRE and 46 healthy volunteers. Of the DRE cohort, 63 had lateralized EMTL (48 left, 15 right). High‐resolution brain MRIs were segmented and analyzed to obtain normalized amygdala and hippocampal volumes. An asymmetry index (AI) assessed directionality, and absolute AI measured magnitude. Atrophy and hypertrophy were defined relative to healthy medians using robust dispersion thresholds. Group comparisons incorporated correction for multiple testing. Results: Dual pathology with mesial temporal sclerosis was radiologically identified in 20.6% of EMTL cases, predominantly ipsilateral. Adjusted amygdala and hippocampal volumes did not differ significantly across groups, and consistent amygdala atrophy was not observed. Left EMTL showed increased hippocampal asymmetry magnitude and a 39.6% prevalence of ipsilateral hippocampal atrophy, comparable to left TLE (34%). Right EMTL showed loss of the physiologic left‐smaller‐than‐right hippocampal pattern, with hypertrophy in the right amygdala (40%), left amygdala (46.7%), and contralateral hippocampus (40%), as well as ipsilateral hippocampal atrophy in 26.7%. Significance: We found mesial temporal volumetric changes in a significant proportion of EMTL patients. Directional, magnitude, and outlier‐based analyses help disentangle coexisting atrophy and hypertrophy, revealing potential compensatory network‐level changes in EMTL‐associated DRE not previously identified. Plain Language Summary: This study looked at changes in two brain structures, the amygdala and hippocampus, in people with treatment‐resistant epilepsy associated with lesions outside the medial temporal lobe. We found that patients with lesions on the left side often had a small left hippocampus, while those with right‐sided lesions showed more complex patterns, including enlargement of both the amygdala and left hippocampus and less frequent small right hippocampus. These findings suggest that detailed measurements of brain asymmetry can uncover changes missed by standard assessment and may help doctors better locate seizure activity and plan treatments.
- Open Access
- 18 June 2025
- Published by SAGE Publications in Epilepsy Currents
Imaging Epilepsy: Past, Passing, and to Come
New imaging techniques appearing over the last few decades have replaced procedures that were uncomfortable, of low specificity, and prone to adverse events. While computed tomography remains useful for imaging patients with seizures in acute settings, structural magnetic resonance imaging (MRI) has become the most important imaging modality for epilepsy evaluation, with adjunctive functional imaging also increasingly well established in presurgical evaluation, including positron emission tomography (PET), single photon ictal-interictal subtraction computed tomography co-registered to MRI and functional MRI for preoperative cognitive mapping. Neuroimaging in inherited metabolic epilepsies is integral to diagnosis, monitoring, and assessment of treatment response. Neurotransmitter receptor PET and magnetic resonance spectroscopy can help delineate the pathophysiology of these disorders. Machine learning and artificial intelligence analyses based on large MRI datasets composed of healthy volunteers and people with epilepsy have been initiated to detect lesions that are not found visually, particularly focal cortical dysplasia. These methods, not yet approved for patient care, depend on careful clinical correlation and training sets that fully sample broad populations.
- 18 June 2025
- Published by SAGE Publications in Epilepsy Currents
Open AccessImaging Epilepsy: Past, Passing, and to Come
New imaging techniques appearing over the last few decades have replaced procedures that were uncomfortable, of low specificity, and prone to adverse events. While computed tomography remains useful for imaging patients with seizures in acute settings, structural magnetic resonance imaging (MRI) has become the most important imaging modality for epilepsy evaluation, with adjunctive functional imaging also increasingly well established in presurgical evaluation, including positron emission tomography (PET), single photon ictal-interictal subtraction computed tomography co-registered to MRI and functional MRI for preoperative cognitive mapping. Neuroimaging in inherited metabolic epilepsies is integral to diagnosis, monitoring, and assessment of treatment response. Neurotransmitter receptor PET and magnetic resonance spectroscopy can help delineate the pathophysiology of these disorders. Machine learning and artificial intelligence analyses based on large MRI datasets composed of healthy volunteers and people with epilepsy have been initiated to detect lesions that are not found visually, particularly focal cortical dysplasia. These methods, not yet approved for patient care, depend on careful clinical correlation and training sets that fully sample broad populations.
- Open Access
- 17 June 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (4) , 1123-1135
Water exchange across the blood–brain barrier and epilepsy: Review on pathophysiology and neuroimaging
The blood–brain barrier (BBB) is a barrier protecting the brain and a milieu of continuous exchanges between blood and brain. There is emerging evidence that the BBB plays a major role in epileptogenesis and drug‐resistant epilepsy, through several mechanisms, such as water homeostasis dysregulation, overexpression of drug transporters, and inflammation. Studies have shown abnormal water homeostasis in epileptic tissue and altered aquaporin‐4 water channel expression in animal epilepsy models. This review focuses on abnormal water exchange in epilepsy and describes recent non‐invasive MRI methods of quantifying water exchange.Plain Language Summary: Abnormal exchange between blood and brain contribute to seizures and epilepsy. The authors describe why correct water balance is necessary for healthy brain functioning and how it is impacted in epilepsy. This review also presents recent MRI methods to measure water exchange in human brain. These measures would improve our understanding of factors leading to seizures.
- 17 June 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (4) , 1123-1135
Open AccessWater exchange across the blood–brain barrier and epilepsy: Review on pathophysiology and neuroimaging
The blood–brain barrier (BBB) is a barrier protecting the brain and a milieu of continuous exchanges between blood and brain. There is emerging evidence that the BBB plays a major role in epileptogenesis and drug‐resistant epilepsy, through several mechanisms, such as water homeostasis dysregulation, overexpression of drug transporters, and inflammation. Studies have shown abnormal water homeostasis in epileptic tissue and altered aquaporin‐4 water channel expression in animal epilepsy models. This review focuses on abnormal water exchange in epilepsy and describes recent non‐invasive MRI methods of quantifying water exchange.Plain Language Summary: Abnormal exchange between blood and brain contribute to seizures and epilepsy. The authors describe why correct water balance is necessary for healthy brain functioning and how it is impacted in epilepsy. This review also presents recent MRI methods to measure water exchange in human brain. These measures would improve our understanding of factors leading to seizures.
- 1 April 2024
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 14 (2) , e200259
Disparities in Epilepsy Diagnosis and Management in High-Income Countries
Currently, an estimated 3.4 million people in the United States live with epilepsy. Previous studies have identified health disparities associated with race/ethnicity, socioeconomic status (SES), sex, insurance status, and age in this population. However, there has been a dearth of research addressing these disparities. We performed a literature review of articles published between 2010 and 2020 pertaining to health disparities in people with epilepsy (PWE), identified key factors that contribute to gaps in their care, and discussed possible solutions. Health disparities in prevalence, treatment access, time to diagnosis, health care delivery and engagement, and clinical outcomes were identified among individuals who were either of low SES, rural-based, uninsured/underinsured, older patients, patients of color, or female sex. Disparities in care for PWE continue to persist. Greater priority should be placed on addressing these gaps intricately tied to sociodemographic factors. Reforms to mitigate health disparities in PWE are necessary for timely diagnosis, effective treatment, and positive long-term outcomes.
- 1 April 2024
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 14 (2) , e200259
Disparities in Epilepsy Diagnosis and Management in High-Income Countries
Currently, an estimated 3.4 million people in the United States live with epilepsy. Previous studies have identified health disparities associated with race/ethnicity, socioeconomic status (SES), sex, insurance status, and age in this population. However, there has been a dearth of research addressing these disparities. We performed a literature review of articles published between 2010 and 2020 pertaining to health disparities in people with epilepsy (PWE), identified key factors that contribute to gaps in their care, and discussed possible solutions. Health disparities in prevalence, treatment access, time to diagnosis, health care delivery and engagement, and clinical outcomes were identified among individuals who were either of low SES, rural-based, uninsured/underinsured, older patients, patients of color, or female sex. Disparities in care for PWE continue to persist. Greater priority should be placed on addressing these gaps intricately tied to sociodemographic factors. Reforms to mitigate health disparities in PWE are necessary for timely diagnosis, effective treatment, and positive long-term outcomes.
Sleep physiology in patients with epilepsy: Influence of seizures on rapid eye movement (REM) latency and REM duration
Objective: A well‐established bidirectional relationship exists between sleep and epilepsy. Patients with epilepsy tend to have less efficient sleep and shorter rapid eye movement (REM) sleep. Seizures are far more likely to arise from sleep transitions and non‐REM sleep compared to REM sleep. Delay in REM onset or reduction in REM duration may have reciprocal interactions with seizure occurrence. Greater insight into the relationship between REM sleep and seizure occurrence is essential to our understanding of circadian patterns and predictability of seizure activity. We assessed a cohort of adults undergoing evaluation of drug‐resistant epilepsy to examine whether REM sleep prior to or following seizures is delayed in latency or reduced in quantity.Methods: We used a spectrogram‐guided approach to review the video‐electroencephalograms of patients' epilepsy monitoring unit admissions for sleep scoring to determine sleep variables.Results: In our cohort of patients, we found group‐ and individual‐level delay of REM latency and reduced REM duration when patients experienced a seizure before the primary sleep period (PSP) of interest or during the PSP of interest. A significant increase in REM latency and decrease in REM quantity were observed on nights where a seizure occurred within 4 h of sleep onset. No change in REM variables was found when investigating seizures that occurred the day after the PSP of interest. Our study is the first to provide insight about a perisleep period, which we defined as 4‐h periods before and after the PSP.Significance: Our results demonstrate a significant relationship between seizures occurring prior to the PSP, during the PSP, and in the 4‐h perisleep period and a delay in REM latency. These findings have implications for developing a biomarker of seizure detection as well as longer term seizure risk monitoring.
Sleep physiology in patients with epilepsy: Influence of seizures on rapid eye movement (REM) latency and REM duration
Objective: A well‐established bidirectional relationship exists between sleep and epilepsy. Patients with epilepsy tend to have less efficient sleep and shorter rapid eye movement (REM) sleep. Seizures are far more likely to arise from sleep transitions and non‐REM sleep compared to REM sleep. Delay in REM onset or reduction in REM duration may have reciprocal interactions with seizure occurrence. Greater insight into the relationship between REM sleep and seizure occurrence is essential to our understanding of circadian patterns and predictability of seizure activity. We assessed a cohort of adults undergoing evaluation of drug‐resistant epilepsy to examine whether REM sleep prior to or following seizures is delayed in latency or reduced in quantity.Methods: We used a spectrogram‐guided approach to review the video‐electroencephalograms of patients' epilepsy monitoring unit admissions for sleep scoring to determine sleep variables.Results: In our cohort of patients, we found group‐ and individual‐level delay of REM latency and reduced REM duration when patients experienced a seizure before the primary sleep period (PSP) of interest or during the PSP of interest. A significant increase in REM latency and decrease in REM quantity were observed on nights where a seizure occurred within 4 h of sleep onset. No change in REM variables was found when investigating seizures that occurred the day after the PSP of interest. Our study is the first to provide insight about a perisleep period, which we defined as 4‐h periods before and after the PSP.Significance: Our results demonstrate a significant relationship between seizures occurring prior to the PSP, during the PSP, and in the 4‐h perisleep period and a delay in REM latency. These findings have implications for developing a biomarker of seizure detection as well as longer term seizure risk monitoring.
- Open Access
- 17 February 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (2) , 750-757
Long‐term outcomes after new onset seizure in children living with HIV: A cohort study
Objective: To determine the long‐term outcomes, including mortality and recurrent seizures, among children living with HIV (CLWH) who present with new onset seizure.Methods: Zambian CLWH and new onset seizure were enrolled prospectively to determine the risk of and risk factors for recurrent seizures. Demographic data, clinical profiles, index seizure etiology, and 30‐day mortality outcomes were previously reported. After discharge, children were followed quarterly to identify recurrent seizures and death. Given the high risk of early death, risk factors for recurrent seizure were evaluated using a model that adjusted for mortality.Results: Among 73 children enrolled, 28 died (38%), 22 within 30‐days of the index seizure. Median follow‐up was 533 days (IQR 18–957) with 5% (4/73) lost to follow‐up. Seizure recurrence was 19% among the entire cohort. Among children surviving at least 30‐days after the index seizure, 27% had a recurrent seizure. Median time from index seizure to recurrent seizure was 161 days (IQR 86–269). Central nervous system opportunistic infection (CNS OI), as the cause for the index seizure was protective against recurrent seizures and higher functional status was a risk factor for seizure recurrence.Significance: Among CLWH presenting with new onset seizure, mortality risks remain elevated beyond the acute illness period. Recurrent seizures are common and are more likely in children with higher level of functioning even after adjusting for the outcome of death. Newer antiseizure medications appropriate for co‐usage with antiretroviral therapies are needed for the care of these children. CNS OI may represent a potentially reversible provocation for the index seizure, while seizures in high functioning CLWH without a CNS OI may be the result of a prior brain injury or susceptibility to seizures unrelated to HIV and thus represent an ongoing predisposition to seizures.Plain Language Summary: This study followed CLWH who experienced a new onset seizure to find out how many go on to have more seizures and identify any patient characteristics associated with having more seizures. The study found that mortality rates continue to be high beyond the acute clinical presentation with new onset seizure. Children with a CNS OI causing the new onset seizure had a lower risk of later seizures, possibly because the trigger for the seizure can be treated. In contrast, high functioning children without a CNS OI were at higher risk of future seizures.
- 17 February 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (2) , 750-757
Open AccessLong‐term outcomes after new onset seizure in children living with HIV: A cohort study
Objective: To determine the long‐term outcomes, including mortality and recurrent seizures, among children living with HIV (CLWH) who present with new onset seizure.Methods: Zambian CLWH and new onset seizure were enrolled prospectively to determine the risk of and risk factors for recurrent seizures. Demographic data, clinical profiles, index seizure etiology, and 30‐day mortality outcomes were previously reported. After discharge, children were followed quarterly to identify recurrent seizures and death. Given the high risk of early death, risk factors for recurrent seizure were evaluated using a model that adjusted for mortality.Results: Among 73 children enrolled, 28 died (38%), 22 within 30‐days of the index seizure. Median follow‐up was 533 days (IQR 18–957) with 5% (4/73) lost to follow‐up. Seizure recurrence was 19% among the entire cohort. Among children surviving at least 30‐days after the index seizure, 27% had a recurrent seizure. Median time from index seizure to recurrent seizure was 161 days (IQR 86–269). Central nervous system opportunistic infection (CNS OI), as the cause for the index seizure was protective against recurrent seizures and higher functional status was a risk factor for seizure recurrence.Significance: Among CLWH presenting with new onset seizure, mortality risks remain elevated beyond the acute illness period. Recurrent seizures are common and are more likely in children with higher level of functioning even after adjusting for the outcome of death. Newer antiseizure medications appropriate for co‐usage with antiretroviral therapies are needed for the care of these children. CNS OI may represent a potentially reversible provocation for the index seizure, while seizures in high functioning CLWH without a CNS OI may be the result of a prior brain injury or susceptibility to seizures unrelated to HIV and thus represent an ongoing predisposition to seizures.Plain Language Summary: This study followed CLWH who experienced a new onset seizure to find out how many go on to have more seizures and identify any patient characteristics associated with having more seizures. The study found that mortality rates continue to be high beyond the acute clinical presentation with new onset seizure. Children with a CNS OI causing the new onset seizure had a lower risk of later seizures, possibly because the trigger for the seizure can be treated. In contrast, high functioning children without a CNS OI were at higher risk of future seizures.
- Open Access
- 1 April 2022
- Published by Wiley in Epilepsia Open
- Vol. 7 (2) , 315-324
Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era
Objective: This study describes clinical profiles including human immunodeficiency virus (HIV) disease history and seizure etiology among children living with HIV presenting with new‐onset seizure during the era of antiretroviral therapy (ART) in Zambia. 30‐day mortality and cause of death are also reported.Methods: Children living with HIV (CLWHIV) with new‐onset seizures were prospectively evaluated at one large urban teaching hospital and two non‐urban healthcare facilities. Interviews with family members, review of medical records, and where needed, verbal autopsies were undertaken. Two clinicians who were not responsible for the patients' care independently reviewed all records and assigned seizure etiology and cause of death with adjudication as needed.Results: From April 2016 to June 2019, 73 children (49 urban, 24 rural) were identified. Median age was 6 years (IQR 2.2‐10.0) and 39 (53%) were male children. Seizures were focal in 36 (49%) and were often severe, with 37% presenting with multiple recurrent seizures in the 24 hours before admission or in status epilepticus. Although 36 (49%) were on ART at enrollment, only 7 of 36 (19%) were virally suppressed. Seizure etiologies were infectious in over half (54%), with HIV encephalitis, bacterial meningitis, and tuberculous meningitis being the most common. Metabolic causes (19%) included renal failure and hypoglycemia. Structural lesions identified on imaging accounted for 10% of etiologies and included stroke and non‐accidental trauma. No etiology could be identified in 12 (16%) children, most of whom died before the completion of clinical investigations. Twenty‐two (30%) children died within 30 days of the index seizure.Significance: Despite widespread ART roll out in Zambia, new‐onset seizure in CLWHIV occurs in the setting of advanced, active HIV disease. Seizure severity/burden is high as is early mortality. Enhanced programs to assure early ART initiation, improve adherence, and address ART failure are needed to reduce the burden of neurological injury and premature death in CLWHIV.
- 1 April 2022
- Published by Wiley in Epilepsia Open
- Vol. 7 (2) , 315-324
Open AccessClinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era
Objective: This study describes clinical profiles including human immunodeficiency virus (HIV) disease history and seizure etiology among children living with HIV presenting with new‐onset seizure during the era of antiretroviral therapy (ART) in Zambia. 30‐day mortality and cause of death are also reported.Methods: Children living with HIV (CLWHIV) with new‐onset seizures were prospectively evaluated at one large urban teaching hospital and two non‐urban healthcare facilities. Interviews with family members, review of medical records, and where needed, verbal autopsies were undertaken. Two clinicians who were not responsible for the patients' care independently reviewed all records and assigned seizure etiology and cause of death with adjudication as needed.Results: From April 2016 to June 2019, 73 children (49 urban, 24 rural) were identified. Median age was 6 years (IQR 2.2‐10.0) and 39 (53%) were male children. Seizures were focal in 36 (49%) and were often severe, with 37% presenting with multiple recurrent seizures in the 24 hours before admission or in status epilepticus. Although 36 (49%) were on ART at enrollment, only 7 of 36 (19%) were virally suppressed. Seizure etiologies were infectious in over half (54%), with HIV encephalitis, bacterial meningitis, and tuberculous meningitis being the most common. Metabolic causes (19%) included renal failure and hypoglycemia. Structural lesions identified on imaging accounted for 10% of etiologies and included stroke and non‐accidental trauma. No etiology could be identified in 12 (16%) children, most of whom died before the completion of clinical investigations. Twenty‐two (30%) children died within 30 days of the index seizure.Significance: Despite widespread ART roll out in Zambia, new‐onset seizure in CLWHIV occurs in the setting of advanced, active HIV disease. Seizure severity/burden is high as is early mortality. Enhanced programs to assure early ART initiation, improve adherence, and address ART failure are needed to reduce the burden of neurological injury and premature death in CLWHIV.
- Open Access
- 8 August 2021
- Published by Wiley in Epilepsia Open
- Vol. 6 (4) , 777-780
Human herpesvirus 6 and epilepsy
We investigated the association between human herpesvirus 6 (HHV‐6) and mesial temporal sclerosis (MTS) in 87 patients who had surgery for drug‐resistant epilepsy. Fifty‐four had MTS, 22 focal cortical dysplasia (FCD), four tumors, three vascular malformations, and three a history of encephalitis. We extracted DNA from fresh brain tissue immediately after surgery and performed viral detection with quantitative real‐time polymerase chain reaction (PCR) or digital droplet PCR specific for HHV‐6A and HHV‐6B. Tissue was studied with standard clinical techniques, including hematoxylin and eosin, glial fibrillary acidic protein, and NeuN stains. Twenty‐nine of 54 patients with MTS, six of 23 with focal cortical dysplasia (FCD), and one of three with a history of encephalitis were positive for HHV‐6 (P < .02). Febrile seizure history was not associated with HHV‐6 detection. Patients with MTS had significantly lower seizure onset age than those with other pathologies. Thirteen patients had positron emission tomography with [11C]PBR28, a marker for reactive astrocytes and activated microglia; there was a trend for HHV‐6‐positive patients to have higher binding in their seizure foci, suggesting inflammation. Our study supports a potential role for HHV‐6 in the etiology of MTS.
- 8 August 2021
- Published by Wiley in Epilepsia Open
- Vol. 6 (4) , 777-780
Open AccessHuman herpesvirus 6 and epilepsy
We investigated the association between human herpesvirus 6 (HHV‐6) and mesial temporal sclerosis (MTS) in 87 patients who had surgery for drug‐resistant epilepsy. Fifty‐four had MTS, 22 focal cortical dysplasia (FCD), four tumors, three vascular malformations, and three a history of encephalitis. We extracted DNA from fresh brain tissue immediately after surgery and performed viral detection with quantitative real‐time polymerase chain reaction (PCR) or digital droplet PCR specific for HHV‐6A and HHV‐6B. Tissue was studied with standard clinical techniques, including hematoxylin and eosin, glial fibrillary acidic protein, and NeuN stains. Twenty‐nine of 54 patients with MTS, six of 23 with focal cortical dysplasia (FCD), and one of three with a history of encephalitis were positive for HHV‐6 (P < .02). Febrile seizure history was not associated with HHV‐6 detection. Patients with MTS had significantly lower seizure onset age than those with other pathologies. Thirteen patients had positron emission tomography with [11C]PBR28, a marker for reactive astrocytes and activated microglia; there was a trend for HHV‐6‐positive patients to have higher binding in their seizure foci, suggesting inflammation. Our study supports a potential role for HHV‐6 in the etiology of MTS.